China is quietly taking control of US medicine. We must stop helping it.
China is using economic leverage to dominate the global supply chain for medicines, and the U.S. must take action to protect its leadership in the biomedical industry by strengthening regulatory frameworks and investing in domestic infrastructure.
China is using economic leverage to dominate the global supply chain for medicines, and the U.S. must take action to protect its leadership in the biomedical industry by strengthening regulatory frameworks and investing in domestic infrastructure.
This report comes from The Hill. The story centres on China is quietly taking control of US medicine. We must stop helping it.. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from The Hill and related outlets covering this beat.

